-
Name:
Dr. Chandrakant Bonde
-
Designation:
Principal (M.Pharm, Ph.D, MBA)
-
Specialization:
Pharmaceutical and Medicinal Chemistry
-
Email :
chandrakant.bonde@ssrpharmacy.edu.in
-
Total Experience:
24
- Follow Us:
Interest areas
- Design and development of new chemical entities (NCEs) as anti-HIV and Antitubercular agents.
- Computer aided drug design
- Stability indicating method development using LC-MS
- Analytical and bio analytical method development of Active Pharmaceutical Ingredients (APIs)
- Impurity synthesis of API
Research
- Publications – 95 (International- 65, National-30)
- Presentations- 15 (International- 06, National- 9)
- Government-funded projects – 02
- Consultancy Project: 02
- Seed grant project :03
- Government fellowship – 1 (BOYSCAST Fellwship) Science and Engineering Research Board (SERB), Department of Science and Technology (DST)
Awards
- Recipient of BOYSCAST fellowship from Department of science and technology, New Delhi to carry out the research work St. John’s university New York.
- Recipient of Most Cited Research Article award 2003-2006 from Elsevier Ltd, Oxford, UK.,
- Received Junior Research Fellowship from Haffkine Institute for Training Research and Testing in the year 1998-2001.
Conferences/Workshops/Seminars attended
- Fifty six conferences are attended including national and international.
Professional Memberships
- Association of Pharmaceutical Teachers of India (APTI) – Life Membership
- Indian Society of Technical Education
- Indian Pharmaceutical Association
- International congress of chemistry and environment
Recent Publications
- Dabhi, M., Parmar, I., & Bonde, C. (2026). Targeting Estrogen Pathways in Breast Cancer: A Review of Current Therapies and Emerging Strategies. Cell Biochemistry and Function, 44(1), e70166.
-
Patil, H., Kute, P., Bonde, C., Bhole, R., Chaudhari, S., Gawad, J., … Bhattarai, A. (2026). Repurposing of FDA-Approved Antiviral Drugs against Monkey Pox Virus: A Computational Targeting of VP39 Methyl transferase. In Silico Research in Biomedicine, 100259.
- Sah, M. K., Pathak, R., Maharjan, J., Gawad, J., Palkar, M., Bonde, C., & Bhattarai, A. (2026). Leveraging Carbon Quantum Dots to Achieve UN Sustainable Development Goals in the Face of Climate Change. Climate Resilience and Sustainability, 5(1), e70034.
- Dange, H., Bonde, C., Bonde, S., Pandya, K., Kumar, D., & Gawad, J. (2026). Artificial intelligence enhanced CRISPR based epigenomic editing: A brighter future in precision medicine. Human Gene, 201565.
- Thombre, S., Bonde, C., Kharkar, P., & Gawad, J. (2026). Comparative evaluation and selection of optimal QSAR-based machine learning model for liver toxicity prediction. Molecular Diversity, 1–21.
- Solanki, Y., Bonde, S., Sonwane, S., & Bonde, C. (2026). Chitosan derivatives for functional hydrogels: Advances, applications, and future prospects. Reactive and Functional Polymers, 106873.
- Thombre, S., Bonde, C., Bhole, R., Gawad, J., & Karwa, P. (2026). Artificial intelligence in impurity prediction: current landscape, challenges, and future directions. Journal of Computer-Aided Molecular Design, 40(1), 186.
- Shelke, M., Hussain, A., Bonde, C., Siddique, M. U. M., Danishuddin, Altamimi, M. A., … Alnemer, O. A. (2026). HSPiP, QbD, and Zeneth based green analysis and stability study of valsartan in the presence of mutagenic impurities: an in-silico study for predicting drug safety and quality control. Journal of Analytical Science and Technology, 17(1), 43.